Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (391)	1/19/2001 11:17:33 AM
From: keokalani'nui	Read Replies (2) \| Respond to of 1784

APBiotech's MegaBACE(TM) DNA Sequencers Lead in China and Brazil PISCATAWAY, N.J., Jan. 19 /PRNewswire/ -- Amersham Pharmacia Biotech (APBiotech) announced today that it has completed the sale of more than 60 of its MegaBACE(TM) DNA Analysis Systems to major institutes in China and Brazil. APBiotech now has a market leading and substantial presence in the rapidly growing Latin American and Asia Pacific high throughput sequencing markets, which have more than doubled in size over the last two years. In Brazil, the National Council of Technologic and Scientific Development of the Science and Technology Ministry purchased 25 MegaBACE 500 systems. These will be used for the Brazilian Genome Project, which aims to stimulate and increase genomic research with a network of laboratories in 15 different states. Their output will be integrated through a bioinformatics laboratory in Rio de Janeiro where the sequences received from all laboratories will be processed. The first organism to be sequenced will be the Chromobacterium violaceum, a bacteria of the Rio Negro in the Amazon region. Understanding this organism could lead to the development of new drugs for the treatment of Chagas Illness and Leishimaniosis, two infectious diseases found in Central and South America. In China, over 35 MegaBACE 1000 systems were purchased by Hangzhou Genomics Institute, a subsidiary of Beijing Genomics Institute, now one of the largest sequencing centers in the world. In addition to further work on the human genome, the Institute has undertaken two major projects to sequence the super hybrid rice developed by Professor Yuan Longping at the National Center of Hybrid Rice Development in Hunan province, and the Sino-Danish collaboration in swine genome project, using the MegaBACE platform. >>snip<< prnewswire.com